Arrowhead Pharmaceuticals Inc. will hold its 2026 Annual Meeting of Stockholders on March 19, 2026. At the meeting, stockholders will vote on the election of seven directors to serve until the next annual meeting, an advisory vote to approve executive compensation, the approval of the Amended and Restated 2021 Incentive Plan, and the ratification of KPMG LLP as independent auditors for the fiscal year ending September 30, 2026. Stockholders may also address any other matters that properly come before the meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arrowhead Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000879407-26-000019), on January 27, 2026, and is solely responsible for the information contained therein.